Real Life Sciences offers Erythropoietin Alpha Recombinant Protein. Real Life Sciences is a research-driven, biotechnology-led, life sciences organization. Erythropoietin Alpha Recombinant Protein is a glycoprotein containing 165 amino acids. Erythropoietin Alpha Recombinant Protein conventionally used to reverse anemic condition that is arising because of body`s inability to produce required amount of erythropoietin, and thus, reduced pool of red blood cells. It is used as a support therapy in the treatment of Acute, chronic and end-stage renal failure; in cancer-induced and chemotherapy-related anemia; in patients undergoing major surgeries; and in AIDS patients on zidovudine treatment. The aim of therapy is to reduce the number of dialysis required by the renal failure patients, better tolerance of chemotherapy and reduced number of blood transfusions in case of cancer patients; and overall improved quality of life in these patients.
